• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

FDA will allow Merial to import limited amounts of European version of Immiticide

September 30, 2011

Rockville, Md. -- The U.S. Food and Drug Administration (FDA) announced today that it would allow Merial to import limited quantities of Immiticide from a European supplier to address concerns over a shortage of the drug to treat heartworm infection in dogs.

Rockville, Md.

-- The U.S. Food and Drug Administration (FDA) announced today that it would allow Merial to import limited quantities of Immiticide from a European supplier to address concerns over a shortage of the drug to treat heartworm infection in dogs.

FDA says the arrangement for U.S. veterinarians is temporary while Merial works out technical issues in the plant where Immiticide is manufactured for this market. Merial’s European supplier is an approved source of the product for international markets, but only has a limited supply for importation into the United States. The amount of product entering the country sometime this month will only satisfy a fraction of the U.S. demand, FDA notes. Therefore, the agency is asking veterinarians to be conservative in their use of the drug.

The imported Immiticide will only be available through a restricted distribution program directly from Merial. The drug will not be available through any of the manufacturer's distributors or for purchase to stock clinic inventory, FDA says. The agency notes that the packaging of the imported product is intended for the European market and does not meet U.S. regulatory requirements, so Merial will include the U.S. Immiticide package insert with each shipment.

Shortly after Merial announced the impending shortage of Immiticide, orders from veterinarians flooded in and wiped out the company’s supply of the drug, Merial says. The resulting shortage could last for weeks or months, the company adds. Until supplies of the heartworm treatment stabilize, Merial says it has recorded requests from veterinarians and will contact those veterinarians when supplies become available.

Advertisement

Additional questions can be directed to Merial at (888) 637-4251.

As previously reported by

DVM Newsmagazine

, the American Heartworm Society crafted a set of guidelines to help veterinarians with the treatment of heartworm positive dogs.

In fact, the AHS recommendations include:

· Reduce potential pathology from infection

· Maintain the health of the heartworm-positive dog until it can be appropriately treated

· Prevent additional heartworm infection of the dog.

Management steps include:

· Verification of heartworm status

· Pretreatment of heartworm-positive dogs to prevent shock

· Careful administration of a macrocyclic lactone heartworm preventive, followed by clinical observation for at least eight hours

· Continuous administration of a heartworm preventive on the regular dosing schedule

· Administration of doxycycline on a one-month-on/two-months-off schedule

· Restricted activity and exercise of the heartworm-positive dog throughout the management period · Medical treatment of symptomatic heartworm infection to relieve signs of respiratory disease, with surgical options weighed for dogs exhibiting cardiovascular compromise

· Retesting for heartworm status before treatment with adulticide treatment once the product is again available.

Related Content:

Breaking News
Veterinarian kills 2 police officers in Mississippi
Veterinarian kills 2 police officers in Mississippi
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals

Advertisement

Latest News

An update on copper concerns in pet foods

Dental hacks to make every case more manageable

Q&A with a keynote: Walter Brown, RVTg, VTS, ECC

News wrap-up: This week’s headlines, plus dvm360® launches its first CE podcast

View More Latest News
Advertisement